IPCalculus - Monoclonal Antibody Therapy Patenting Acti

Views:
 
     
 

Presentation Description

Monoclonal Antibody Therapy patent landscape report contains patenting activity by top assignees, top university/research institute, by publication year, by application year, by priority year, by top IPC class, by top US class, and geographical patenting activity. For more details send your request on info@ipcalculus.com OR contact us on +1-619-618-0414

Comments

By: gary.neal (107 month(s) ago)

Would you suggest monoclonal antibody therapy? I know it's coming around and I just want a professional opinion on the matter. My friend referenced me to the site http://www.goodwinbio.com. What do you think?

Presentation Transcript

Slide 1: 

http://www.ipcalculus.com 2010 © IPCalculus Services info@ipcalculus.com Patenting activity in Monoclonal Antibody Therapy

Slide 2: 

http://www.ipcalculus.com info@ipcalculus.com Contents 2010 © IPCalculus Services

Slide 3: 

http://www.ipcalculus.com info@ipcalculus.com Overview 2010 © IPCalculus Services Monoclonal Antibody Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are the same because they are made by identical immune cells that are all clones of a unique parent cell. They can also be define as any of the highly specific antibodies produced in large quantity by the clones of a single hybrid cell formed in the laboratory by the fusion of a B cell with a tumor cell. Monoclonal Antibody Therapy Monoclonal Antibody Therapy is Immunotherapy which uses monoclonal antibodies (or mAb) to specifically bind to target cells which then stimulate the patient's immune system to attack target cells. It is possible to create a mAb specific to almost any extracellular/ cell surface target, and thus there is a large amount of research and development currently being undergone to create monoclonals for numerous serious diseases (such as rheumatoid arthritis, multiple sclerosis and different types of cancers).

Slide 4: 

http://www.ipcalculus.com info@ipcalculus.com Technology classification As shown in the above mind map Monoclonal Antibody therapy is further categorized into Type of monoclonal antibody, Method of cell lysis, Targeted cell and Applications. This is the broad level classification of Monoclonal Antibody therapy. We at IPCalculus drill down each level class into niche technology areas. For example above mind map, we have categorize “Type of Monoclonal Antibody”, “Targeted cell” and “Applications” into the niche technology areas. Similarly we drill down other categories up to the last possible level. Our client-tailored report will help to identify competitors and track their IP activity even in to the niche segment of technology areas. Note: To access complete classification & comprehensive landscape report, please contact us at +1-619-618-0414 OR send your query on http://www.ipcalculus.com/contactus.php 2010 © IPCalculus Services

Slide 5: 

http://www.ipcalculus.com info@ipcalculus.com Patent distribution by top Assignee 2010 © IPCalculus Services

Slide 6: 

http://www.ipcalculus.com info@ipcalculus.com Geographical patent distribution Geographical patent distribution with Country code, patent count and percentage 2010 © IPCalculus Services

Slide 7: 

http://www.ipcalculus.com info@ipcalculus.com Patent distribution by top IPC class 2010 © IPCalculus Services

Slide 8: 

http://www.ipcalculus.com info@ipcalculus.com Patent distribution by top US class 2010 © IPCalculus Services

Slide 9: 

http://www.ipcalculus.com info@ipcalculus.com Patent distribution by top ECLA class 2010 © IPCalculus Services

Slide 10: 

http://www.ipcalculus.com info@ipcalculus.com Patent distribution by Application year 2010 © IPCalculus Services

Slide 11: 

http://www.ipcalculus.com info@ipcalculus.com Patent distribution by Publication year 2010 © IPCalculus Services

Slide 12: 

http://www.ipcalculus.com info@ipcalculus.com Patent distribution by Priority year 2010 © IPCalculus Services

Slide 13: 

http://www.ipcalculus.com info@ipcalculus.com 2010 © IPCalculus Services Issued and Published Patent Distribution by Application year

Slide 14: 

http://www.ipcalculus.com info@ipcalculus.com 2010 © IPCalculus Services Issued and Published Patent Distribution by Publication year

Slide 15: 

http://www.ipcalculus.com info@ipcalculus.com 2010 © IPCalculus Services Issued and Published Patent Distribution by Priority year

Slide 16: 

http://www.ipcalculus.com info@ipcalculus.com About IPCalculus IPCalculus is an Intellectual Property research & analytical consulting firm based in India, providing customized services in the form of Patent landscape analysis, Patent portfolio analysis, Patent searches (Prior-art, Patentability/Novelty, Invalidation, Infringement, and Freedom to Operate), Patent alert and monitoring, Legal status updates, Trend analysis, Patent to Product mapping and Patent licensing. Our expertise lies in generating valuable IP intelligence by analyzing patent, non-patent, product, clinical trial, regulatory filing, premarket approval, recalls and other technical & competitive information. Our customized, interactive, dynamic & collaborative reporting system "IP Analytics Manager" integrate patent, non-patent, product, clinical trial, regulatory filing, premarket approval, recalls and other technical & competitive information. We provide consistent high quality IP research & analytical services in the field of medical devices, pharmaceutical, healthcare, biotechnology, life sciences, electronics, telecommunications, FMCG, chemistry, mechanical and many more. 2010 © IPCalculus Services

Slide 17: 

http://www.ipcalculus.com info@ipcalculus.com Contact us For more information please visit http://www.ipcalculus.com OR Send your request from http://www.ipcalculus.com/contactus.php OR Call our sales representative on +1-619-618-0414 2010 © IPCalculus Services

authorStream Live Help